학술논문

Iberdomide (CC-220) is a potent cereblon E3 ligase modulator with antitumor and immunostimulatory activities in lenalidomide- and pomalidomide-resistant multiple myeloma cells with dysregulated CRBN
Document Type
Article
Source
In: Leukemia. (Leukemia, April 2020, 34(4):1197-1201)
Subject
Language
English
ISSN
14765551
08876924